Biotech & Medical Devices
Life Science Insurance & Risk Management
How well does your insurance program adapt as your business moves from research to commercialization?
Life science operations evolve rapidly. A policy written for early-stage R&D may leave a company critically exposed as it initiates clinical trials, navigates regulatory pathways, and begins distributing medical devices or therapeutics. From Colorado and beyond, we can help.
The Evolution of Risk
Anticipating your next phase of development.
1. Research & Development
Protect valuable research equipment, sensitive intellectual property, and laboratory property from loss or interruption before a product even reaches the trial phase.
2. Clinical Trials
Navigate the complex liability and contractual obligations required when moving into human testing, ensuring adequate medical monitoring and indemnification.
3. Commercialization
Scale your coverage for the severe product liability and professional liability exposures that arise once your therapeutics or devices enter the open market.
Life Science Coverages
Targeted protection for specialized exposures.
01
Products Liability
Defend against claims of bodily injury or worsening health conditions allegedly caused by your manufactured medical devices or biopharmaceuticals.
02
Clinical Trials Liability
Address the specialized liability exposures, strict regulatory considerations, and subject injury compensation mechanisms inherent to clinical testing.
03
Professional Liability (E&O)
Protect against financial damages resulting from errors or omissions in contract research, lab testing, or consulting services provided to third parties.
04
Research Equipment & Property
Cover high-value diagnostic machinery, cleanrooms, and perishable biological materials susceptible to spoilage or temperature changes.
05
Cyber Liability
Secure essential protection against the theft of proprietary R&D data, intellectual property, and sensitive patient health information (PHI).
06
Contractual Obligations
Ensure your policies align with the stringent indemnification clauses demanded by universities, research hospitals, and manufacturing partners.
